Theriva Biologics, Inc. Warrants Not Settleable in Cash, Fair Value Disclosure
Theriva Biologics, Inc. (TOVX) had Warrants Not Settleable in Cash, Fair Value Disclosure of $9.00 thousand as of 2018-01-24, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2023-05-11
- 2018-01-24: Warrants Not Settleable in Cash, Fair Value Disclosure $9.00K.
- 2017-12-26: Warrants Not Settleable in Cash, Fair Value Disclosure $9.00K.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2018-01-24 | $9.00K 10-Q · filed 2023-05-11 |
| 2017-12-26 | $9.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |